Opioid Receptor | kappa, mu Opioid Receptor
The Kappa Opioid Receptor | SpringerLink
EX-99.2
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Understanding opioids in veterinary medicine
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Opioid Agonists & Antagonists | Basicmedical Key
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
κ-opioid receptor - Wikipedia
JCI Insight - Kappa opioid receptor signaling protects cartilage tissue against posttraumatic degeneration
Kappa Receptors – Opioid Peptides
κ-opioid receptor - Wikipedia
Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Opioids in cancer: The κ‑opioid receptor (Review)
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Mu Agonist Opioids and Kappa Opioids | Download Table
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Acute Pain Pharmacotherapy
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
